CSE:BHSC - Post Discussion
Post by
Betteryear2 on Apr 06, 2022 1:45pm
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results
- VINIA® sales orders grew 112% compared to Q1 2021 to reach USD 787k
- Reiterating guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7M
- Started the transition of VINIA® production at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to Cannabis
- Produced a unique Cannabis composition in large industrial scale Bioreactors enabling the commercialization and sales of Cannabis products in H2 2022
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 6, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") today announced Q1 2022 sales of its flagship VINIA® product reached USD 787k, representing 112% growth compared to the same quarter of last year.
Be the first to comment on this post